Investors Research Corp Amarin Corp Plcuk Put Options Transaction History
Investors Research Corp
- $493 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMRN
# of Institutions
72Shares Held
55.1MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$370 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$185 Million9.37% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$50.6 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$39.1 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.86MShares$27.7 Million0.04% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.01B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...